A critical appraisal of advances in pediatric nonalcoholic fatty liver disease

Nadia Ovchinsky, Joel E. Lavine

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in children; its rise has been related to the increasing prevalence of obesity. Significant advancements have been made in the investigation of the etiopathogenesis and genetic risk factors for the disease. Pediatric fatty liver disease often displays a histologic pattern distinct from that found in adults, and liver biopsy remains the gold standard for diagnosis of nonalcoholic steatohepatitis (NASH). Lifestyle modifications that result in weight loss remain the first-line treatment of NAFLD in children. Recent adult and pediatric clinical trials on the use of antioxidants combined with lifestyle intervention for NAFLD have demonstrated encouraging results, and additional trials are underway. In this review, the authors provide an overview of current concepts in epidemiology, histologic features, diagnosis, pathophysiology, genetic risk factors, and treatment of NAFLD in children.

Original languageEnglish (US)
Pages (from-to)317-324
Number of pages8
JournalSeminars in Liver Disease
Volume32
Issue number4
DOIs
StatePublished - 2012
Externally publishedYes

Fingerprint

Pediatrics
Life Style
Liver Diseases
Fatty Liver
Weight Loss
Epidemiology
Obesity
Antioxidants
Non-alcoholic Fatty Liver Disease
Clinical Trials
Biopsy
Liver
Therapeutics

Keywords

  • nonalcoholic fatty liver disease (NAFLD)
  • nonalcoholic steatohepatitis (NASH)
  • obesity
  • pediatrics

ASJC Scopus subject areas

  • Hepatology

Cite this

A critical appraisal of advances in pediatric nonalcoholic fatty liver disease. / Ovchinsky, Nadia; Lavine, Joel E.

In: Seminars in Liver Disease, Vol. 32, No. 4, 2012, p. 317-324.

Research output: Contribution to journalArticle

@article{17f8a4047b83400091a8e7512320cd31,
title = "A critical appraisal of advances in pediatric nonalcoholic fatty liver disease",
abstract = "Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in children; its rise has been related to the increasing prevalence of obesity. Significant advancements have been made in the investigation of the etiopathogenesis and genetic risk factors for the disease. Pediatric fatty liver disease often displays a histologic pattern distinct from that found in adults, and liver biopsy remains the gold standard for diagnosis of nonalcoholic steatohepatitis (NASH). Lifestyle modifications that result in weight loss remain the first-line treatment of NAFLD in children. Recent adult and pediatric clinical trials on the use of antioxidants combined with lifestyle intervention for NAFLD have demonstrated encouraging results, and additional trials are underway. In this review, the authors provide an overview of current concepts in epidemiology, histologic features, diagnosis, pathophysiology, genetic risk factors, and treatment of NAFLD in children.",
keywords = "nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), obesity, pediatrics",
author = "Nadia Ovchinsky and Lavine, {Joel E.}",
year = "2012",
doi = "10.1055/s-0032-1329905",
language = "English (US)",
volume = "32",
pages = "317--324",
journal = "Seminars in Liver Disease",
issn = "0272-8087",
publisher = "Thieme Medical Publishers",
number = "4",

}

TY - JOUR

T1 - A critical appraisal of advances in pediatric nonalcoholic fatty liver disease

AU - Ovchinsky, Nadia

AU - Lavine, Joel E.

PY - 2012

Y1 - 2012

N2 - Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in children; its rise has been related to the increasing prevalence of obesity. Significant advancements have been made in the investigation of the etiopathogenesis and genetic risk factors for the disease. Pediatric fatty liver disease often displays a histologic pattern distinct from that found in adults, and liver biopsy remains the gold standard for diagnosis of nonalcoholic steatohepatitis (NASH). Lifestyle modifications that result in weight loss remain the first-line treatment of NAFLD in children. Recent adult and pediatric clinical trials on the use of antioxidants combined with lifestyle intervention for NAFLD have demonstrated encouraging results, and additional trials are underway. In this review, the authors provide an overview of current concepts in epidemiology, histologic features, diagnosis, pathophysiology, genetic risk factors, and treatment of NAFLD in children.

AB - Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in children; its rise has been related to the increasing prevalence of obesity. Significant advancements have been made in the investigation of the etiopathogenesis and genetic risk factors for the disease. Pediatric fatty liver disease often displays a histologic pattern distinct from that found in adults, and liver biopsy remains the gold standard for diagnosis of nonalcoholic steatohepatitis (NASH). Lifestyle modifications that result in weight loss remain the first-line treatment of NAFLD in children. Recent adult and pediatric clinical trials on the use of antioxidants combined with lifestyle intervention for NAFLD have demonstrated encouraging results, and additional trials are underway. In this review, the authors provide an overview of current concepts in epidemiology, histologic features, diagnosis, pathophysiology, genetic risk factors, and treatment of NAFLD in children.

KW - nonalcoholic fatty liver disease (NAFLD)

KW - nonalcoholic steatohepatitis (NASH)

KW - obesity

KW - pediatrics

UR - http://www.scopus.com/inward/record.url?scp=84873400247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873400247&partnerID=8YFLogxK

U2 - 10.1055/s-0032-1329905

DO - 10.1055/s-0032-1329905

M3 - Article

VL - 32

SP - 317

EP - 324

JO - Seminars in Liver Disease

JF - Seminars in Liver Disease

SN - 0272-8087

IS - 4

ER -